Iopamidol (Isovue)

Subscribe to Selected New Research on Iopamidol

225 relevant articles (10 outcomes, 24 trials/studies) found for this Drug

Description: A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.

Also Known As:

Isovue; B-15,000; B-15000; Gastromiro; Iopamidol, (+-)-Isomer; Iopamidol, (R)-Isomer; Iopamidol, Sodium Salt, (S)-Isomer; Iopamiro; Isovue 370; Jopamidol; Niopam; SQ 13,396; Solutrast; Solutrast 370; Solutrast Gastro; B 15,000; B 15000; B15,000; B15000; 1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-

Relationship Network

Drug Context: Research Results

Organic Chemicals: 40

Triiodobenzoic Acids: 2

Iopamidol: 225

iomeprol: 36

C 29 (contrast media)

lipiodol-iopamidol emulsion

Experts

1.	Katzberg, Richard W: 1 article (11/2006)
2.	Ni, Zhou-Hui: 1 article (11/2006)
3.	Heiken, Jay P: 1 article (11/2006)
4.	Lepanto, Luigi: 1 article (11/2006)
5.	Thomsen, Henrik S: 1 article (11/2006)
6.	Barrett, Brendan J: 1 article (11/2006)
7.	Nelson, Rendon: 1 article (11/2006)
8.	Sahani, Dushyant: 1 article (11/2006)
9.	Chen, Nan: 1 article (11/2006)
10.	Ni, Zhao-hui: 1 article (11/2006)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2006 - "Perfusion studies (cine mode; 4 x 5 mm collimation; 1 acquisition/s; 65 seconds total) were performed through the tumor epicenter after IV bolus contrast administration (iopamidol 340, 100 mL; 5 mL/s) and repeated within 48 hours" 07/01/2005 - "A 65-sec dynamic study (cine mode, 4 x 5 mm collimation) was acquired through the tumor after i.v. contrast administration (100 mL of iopamidol 350, 5 mL/sec)" 01/01/1992 - "PATIENTS AND METHODS: Two patients were evaluated after the intrathecal administration of an iodinated nonionic contrast agent (Isovue) and five subjects with cranial tumors following the intravenous administration of an iodinated ionic contrast medium (Renografin)" 01/01/1994 - "Tumor blood-brain transfer constant of iopamidol (K) and plasma volume (Vp) were measured in 10 patients with primary brain tumors before and after 7 days of dexamethasone treatment (4 x 4 mg per oral per day) using X-ray computed tomography" 09/01/1985 - "In a later phase, after contrast administration, however, both iopamidol and ioxaglate should conceal hypodense hepatic tumors less than diatrizoate." Order ALL the reference details at left...
2.	Pain (Aches) 12/01/2006 - "Iopamidol was used as the contrast medium, with a high concentration of 370 mg I/ml and a moderate concentration of 300 mg I/ml. The frequency of adverse reactions, such as pain at the injection site and heat sensation, were determined" 06/01/1989 - "One patient experienced mild pain from injection of iopamidol" 06/01/1985 - "Iopamidol caused substantially less discomfort and pain" 06/01/1985 - "Iopamidol arteriography: discomfort and pain." 11/01/1984 - "A randomized double-blind study was performed in 27 patients to compare the clinical safety, incidence of pain and warmth, and film quality produced by iopamidol and Conray-60 in selective cerebral angiography" Order ALL the reference details at left...
3.	Headache (Headaches) 01/01/1984 - "Among 106 patients undergoing radiculography with a tangent-beam technique and Iopamidol, only 4 developed mild side effects, namely headache in three cases and headache with nausea in one." 05/01/1983 - "The incidence of side effects, notably vomiting and headache, was significantly less with iopamidol but remains appreciable" 04/01/1983 - "Headaches and nausea were less severe using iopamidol" 08/01/1992 - "Sixty percent of the patients suffering from postmyelographic reactions reported delayed headache, which occurred most often with iotrolan rather than iopamidol" 09/01/1989 - "Adverse reactions to iopamidol and iohexol myelography with special attention to headache: role of myelographic technique." Order ALL the reference details at left...
4.	Seizures (Seizure) 01/01/2005 - "Iopamidol myelography may be associated with a risk of seizures" 01/01/2005 - "We describe a case of generalized tonic-clonic seizure after cervical myelography with iopamidol in a previously healthy young man" 01/01/2005 - "Iopamidol, a water-soluble contrast agent, has been rarely associated with seizures" 01/01/2005 - "Iopamidol myelography-induced seizures." 04/01/2004 - "METHODS: We retrospectively identified all patients with seizures/SE associated with 1350 iopamidol myelographies during the last 5 years at our institution" Order ALL the reference details at left...
5.	Pathologic Constriction (Stenosis) 11/01/1990 - "Death, related to abrupt occlusion of a severe left main stenosis occurred in one patient who received Hexabrix, and acute pulmonary edema occurred in one patient who received Isovue" 07/01/1993 - "Ten patients received 30 ml Niopam 300 (Bracco SpA, Milan, Italy) (identical to 18372 mg iopamidol) intravenously into a forearm vein to investigate for occult subclavian stenosis" 05/01/1994 - "This randomised, double-blind, parallel group study was to compare the safety, tolerance and diagnostic efficacy of iomeprol and iopamidol, both at an iodine concentration of 150 mgI/ml, in 40 patients with arterial hypertension who required renal intra-arterial digital subtraction angiography (IA-DSA) for suspected renovascular stenosis" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Diatrizoate (Hypaque)
2.	Iodine
3.	iotrolan (Isovist)
4.	iodixanol (Visipaque)
5.	Ioxaglic Acid (Ioxaglate Meglumine)
6.	Iohexol (Omnipaque)
7.	iomeprol
8.	Diatrizoate Meglumine (Gastrograffin)
9.	Ethiodized Oil (Ethiodol)
10.	Doxorubicin (Adriamycin)

Related Therapies and Procedures

1.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
2.	Renal Dialysis (Hemodialysis)
3.	Nephrectomy
4.	Transplants (Transplant)
5.	Massage (Reflexology)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18530 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>